PatternsRadar
Sign in

FERMENTAFermenta Biotech Limited

NSE
446.15INR-16.15 (-3.49%)Close · 20 Nov 2026
5 Nov 2026Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹1,313 CrMarket cap
—P/E (TTM)
66.2%Delivery

Filings & corporate actions

2 results filed
CSV
Dividend
₹3.75 per share · last 5 Aug 2026
2026
  • 5 NovresultsResults · Q2 FY27 · consolidated and standalone+7.2%NSE
  • 19 OctshareholdingShareholding · 30 Sept 2026-5.2%NSE
  • 11 AugresultsResults · Q1 FY27 · consolidated and standalone-2.1%NSE
  • 5 AugdividendDividend · ₹3.75 per share+0.7%
  • 4 AugshareholdingShareholding · 3 Aug 2026+6.9%NSE

Reaction to results · all yearsrose on day 0 in 1 of 2 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY275 Nov 2026+7.2%+13.9%—4.2×
Q1 FY2711 Aug 2026-2.1%-5.7%+2.2%0.9×
Average+2.5%+4.1%+2.2%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q2 FY27

Revenue YoY—
Profit YoY—
Interest cost YoY—
Revenue QoQ+8.9%
Profit QoQ+0.3%
CAGR2Y3Y4Y5Y6Y7Y
Revenue——————
Profit——————

Key data

Open460.95
Day range442.00 – 460.95
52-week range—
From 52w high—
RSI (14)45.4
ATR (14)25.75
Volume24.6K
Avg volume (20D)74.1K
Rel volume0.33×
Volatility (1Y)56.3%
Turnover₹1.1Cr
Traded value (NSE)₹1.1Cr
VWAP449.56
SMA 50 / 200477.02 / —
Price band20%

Delivery percentage

Latest · 20 Nov 202666.2%
20-day avg48.8%
1-year avg51.3%
Percentile (own history)87th
Range10.0–87.7%
Sessions149

Over the last 20 sessions FERMENTA settled 48.8% of its traded quantity, which is above average for an NSE equity. Its one-year average is 51.3%, so recent sessions are running 2.5 points lower than usual.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield0.84%
Dividend, trailing 12M₹3.75
Paid every year for1 yr
Shareholders16.1K · +8.8% QoQ
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buy52 days ago

Performance returns

1D1W1M3M6M1Y
Price-3.49%-5.90%-2.66%-3.03%+45.71%—

Valuation

Market cap₹1,313 Cr
Market cap (NSE)₹1,313 Cr
Free-float cap₹524 Cr
P/E (TTM)—
EPS (TTM)—
P/B3.1
Net margin (TTM)—
Other income / PBT—
ROE—
Debt / equity0.25
Shares outstanding2.87Cr
Listed4 Aug 2026

Ownership

Promoter60.12%
Promoter Δ QoQ-3.97 pp
Public37.49%
FII1.05%
DII0.00%
Pledged0.00%

Quarterly results · consolidated

Q1 FY27Q2 FY27
Revenue (₹ Cr)121.8132.7
YoY chg——
Net profit (₹ Cr)9.59.4
YoY chg——
Net margin7.8%7.1%
EPS3.343.34

Shareholding over time

By quarter

30 Sept 2026 · promoter 60.12% · public 37.49%
3 Aug 2026: promoter 64.09%30 Sept 2026: promoter 60.12%
2026-082026-09
  • Promoter
  • Public and others
Promoter
60.12%
Public
37.49%
Promoter change
-3.97 pp
Filed
19 Oct 2026
FII
1.05%
DII
0.00%
Promoter pledged
0.00%

Who the public is

Mutual funds
0.00%

0.00 pp QoQ

Insurance
0.00%

0.00 pp QoQ

FPI
1.05%

+0.68 pp QoQ

Retail ≤ ₹2L
20.64%

+1.48 pp QoQ

HNI > ₹2L
10.45%

+1.15 pp QoQ

NRI
0.78%

+0.05 pp QoQ

Bodies corporate
1.84%

+0.65 pp QoQ

Shareholders
16,084

+8.8% QoQ

Major holders

As of 30 Sept 2026
HolderTypeHolding
Krishna DatlaPromoter · Individual36.04%
Satish Varma Azad NadimpallyPromoter · Individual11.73%
Anupama Datla DesaiPromoter · Individual8.70%
Preeti ThakkarPromoter · Individual3.65%
Fermenta Biotech Limited Esop TrustOther2.39%
Rakesh Kantilal ShahIndividual1.72%
Anant JainIndividual1.53%
Krishan Premnarayen .Individual1.38%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

Dividends

since 5 Aug 2026 CSV
Financial yearPaymentsDeclaredAdjusted
FY2026-271₹3.75₹3.75
Ex-dateRecord dateDeclaredAdjusted
5 Aug 2026—₹3.75₹3.75

Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.

52-week highs & lows

Loading…

Each session the stock traded past its previous 52-week high or low, from NSE's daily report; the previous figure is the record it broke. Prices as published, not split-adjusted.

Book closures & record dates

Loading…

NSE's corporate-action calendar: who held the stock on the record date, or through the book-closure window, was entitled to the dividend, bonus, split or rights named.

Insider trades

Insiders net, 30d
₹0
Insiders net, 90d
−₹57.7Cr
Promoters net, 90d
−₹55.3Cr
Insider buyers, 90d
0
Last promoter buy
none on record
Disclosures on record
5
5 open-market of the newest 5
By year
BroadcastPersonSideSharesValuePriceHolding before → afterStakeRegulation
29 Sept 2026Preeti ThakkarPromoterSell11.66L₹55.3Cr474.6522.40L → 10.74L3.65%-3.96 pp7(2)told 29 Sept 2026
9 Sept 2026Sumesh GandhiKMPSell1.6K₹8.2L509.9913.3K → 11.7K0.04%-0.01 pp7(2)told 9 Sept 2026
9 Sept 2026Sumesh GandhiKMPSell200₹98,290491.4513.5K → 13.3K0.04%-0.00 pp7(2)told 9 Sept 2026
9 Sept 2026Sumesh GandhiKMPSell2.1K₹10.6L506.0815.6K → 13.5K0.05%-0.01 pp7(2)told 8 Sept 2026
7 Sept 2026Prashant NagreDirectorSell44.0K₹2.2Cr499.871.39L → 95.4K0.32%-0.15 pp7(2)told 7 Sept 2026

SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.

How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session

Filings

CSV
Loading…

Bulk & block deals · 29 Sept 2026

CSV
9 of 9 deals
By year
DateDealClientQuantityPriceValue
29 Sept 2026Sell · bulkALPHAGREP SECURITIES PRIVATE LIMITED1.67L547.97₹9.1Cr
29 Sept 2026Buy · bulkALPHAGREP SECURITIES PRIVATE LIMITED1.67L547.61₹9.1Cr
29 Sept 2026Sell · bulkQE SECURITIES LLP1.47L547.11₹8.1Cr
29 Sept 2026Buy · bulkQE SECURITIES LLP1.44L551.69₹7.9Cr
28 Sept 2026Sell · bulkTHAKKAR PREETI11.66L474.65₹55.3Cr
28 Sept 2026Buy · bulkMOLECULE VENTURES LIMITED LIABILITY PARTNERSHIP2.57L475.25₹12.2Cr
28 Sept 2026Buy · bulkANANT JAIN2.32L473.92₹11.0Cr
6 Jul 2026Sell · bulkNK SECURITIES RESEARCH PRIVATE LIMITED1.86L391.83₹7.3Cr
6 Jul 2026Buy · bulkNK SECURITIES RESEARCH PRIVATE LIMITED1.86L391.34₹7.3Cr

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Takeover-code disclosures

Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Short selling, lending & margin

Loading…

Shares bought on broker margin funding (MTF) and still held at the day’s end, and the amount brokers have lent against them.

Exchange surveillance

20 Nov 2026
  • High-low range > 100% in 6 months · since 4 Aug 2026 — One of the criteria NSE’s surveillance watches: high-low range > 100% in 6 months.

Price band: 20% · not in the F&O ban.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures.

Every stock on this session →

Financials · quarterly statement

₹ crore, as filed
 Q1 FY27Q2 FY27
Revenue from operations121.8132.7
Other income4.43.1
Total income126.2135.8
Total expenses111.5121.5
└ Finance costs2.53.7
└ Depreciation5.25.2
Profit before tax14.714.2
Tax expense5.24.8
Net profit9.59.4
EPS3.403.40
Net margin7.82%7.11%
PBT margin12.06%10.74%
Tax rate35.12%33.77%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 5 Nov 2026.

2 quarters on file; a year-on-year comparison needs five.

Balance sheet & cash flow · half-yearly

₹ crore, as filed

Balance sheet

 H1 FY27
Total assets695.7
Current assets423.4
└ Cash & equivalents29.7
└ Other bank balances29.4
└ Current investments0.0
└ Trade receivables120.1
└ Inventories166.9
Total equity412.1
└ Attributable to owners418.1
└ Non-controlling interest(6.0)
└ Share capital14.4
Borrowings104.7
└ Current101.5
└ Non-current3.2
Trade payables92.6
Current liabilities250.4
Total liabilities283.6
Net debt45.6
Debt / equity0.25
Current ratio1.69

Cash flow, year to date

 H1 FY27
Operating cash flow54.8
└ Capex(17.3)
Free cash flow37.5
Investing cash flow(28.3)
Financing cash flow(29.8)
└ Dividends paid(10.8)
└ Buybacks0.0
Net change in cash(3.3)

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

FERMENTA at a glance

  • FERMENTA closed at ₹446.15 on 20 Nov 2026, -3.49% on the day.
  • Delivery was 66.2% of traded quantity on 20 Nov 2026, the 87th percentile of its own 149 sessions with a reading (20-session average 48.8%, 1-year average 51.3%).
  • Market capitalisation is ₹1,313 crore, with no positive trailing earnings for a P/E.
  • Q2 FY27 results (consolidated, filed 5 Nov 2026): revenue ₹133 crore, net profit ₹9 crore; the price moved +7.2% on the first session after.
  • Promoters held 60.12% at 30 Sept 2026, down 3.97 percentage points on the previous filing.

About

Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE225B01021
SeriesEQ
Listed4 Aug 2026
NSE market cap · 17 Nov 2026₹1,370 Cr
Free-float market cap (NSE)₹441 Cr
Shares outstanding (NSE)2.94Cr
History from20 Apr 2026
Sessions149

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.